ORIC-114
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ORIC-114, covering 2025-08-05 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC [Phase 1]